A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma

Autor: Giovanni Apolone, A. Zaniboni, Gianfranco Pavia, R. Labianca, Bruno Andreoni, N. Pinna, Frank E. Johnson, Eva Negri, Gianfranco Pancera, Gerardo Rosati, Sandro Barni, Pietro Sozzi, Roldano Fossati, Valter Torri, G. Solina, Paola Mosconi, G. Ambrosini, F. Gaion, G. Corradini, G. Martignoni, Giovanna Luchena, Sandro Pignata, Bruno Daniele, Marta Monteforte, M. Duro, Giovanni Oliverio

Publikováno v: Annals of Oncology. 27:274-280

Background Colorectal cancer is the third most common and the third most lethal cancer in both men and women in developed countries. About 75% of cases are first diagnosed when the disease is classified as localized or regional, undergo potentially c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f77e62c1981e732e0e1b746c4e2b357
https://doi.org/10.1093/annonc/mdv541

Psychological resources and strengths in adults living with lung cancer. A pilot study

Autor: L. Riccardi, G. Palazzolo, M. Cagnin, S Schivardi, M. Mion, Mariella Sorarù, F. Gaion, R. Cavallo, L. Sartor, A. Morabito, M.T. Simioni, M. Beda, T. Sava

Publikováno v: Annals of Oncology. 28:vi84

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbbae1d15139bd5d902926f2dad7b342
https://doi.org/10.1093/annonc/mdx434.008

Contents, Vol. 52, 1995

Autor: P. Nelli, Enrico Aitini, C. Noberasco, C.P. Lui, L. Beckman, Yoichi Ikeda, Masakuni Noguchi, Sylvie Mazoyer, Ann-Lii Cheng, Masaki Mori, Arnaldo C. Medeiros, Alberto Ravaioli, Franco Desiderio, Franco Frigerio, Junkichi Kim, Gabriele Tancini, Takao Suzuki, Franco Rovelli, A. Bono, Tatsuro Kamakura, Maria Mitzi Brentani, G. Nastasi, Lurdes A. Marques, Massimo Franchi, Fernando Brivio, B. Müller, A. Di Leo, Kun-Huei Yeh, E. Jäger, Hiroshi Nakano, Giovanna Cavazzini, C. Fan, Pier Paolo Fattori, Mitsuharu Earashi, Marina Cazzaniga, U. Stendahl, Flavia Zanaboni, Kazuo Kinoshita, M. Nicolini, F. Gaion, Mikio Makuuchi, Hideaki Nagasaki, Hwei-Fang Tien, Paolo Lissoni, Einar K. Rofstad, Keizo Sugimachi, F. Cappuzzo, E. Bichisao, Maria Aparecida Nagai, Theorickus C. Viljoen, A Tusei, S.K. Kong, N. Zilembo, K.P. Fung, Giuseppina Arcangeli, C.Y. Lee, Haruki Oomori, M. Colleoni, Sandro Barni, N. Stjernberg, Kaoru Kumada, E. Pasquini, Seizo Minagawa, Mauro Moroni, P. Manente, Heidi Lyng, Franco Monti, Casper H. van Aswegen, A. Knuth, Camillo Porta, Maria Enrica Forghieri, Dion J. du Plessis, G. Sgarbossa, O. Klein, Haruo Tateishi, B. Wächter, Jun Sasaki, E. Bajetta, E. Scorbati, Lois M. Mulligan, Itsuo Miyazaki, Masahide Minami, Nicoletta Donadello, Lorenzo Gianni, Kimio Namatame, Antonio Ardizzoia, C. Bartoli, Y.M. Choy, Nobuhiro Koyanagi, U. Braun

Publikováno v: Oncology. 52:I-VI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::443c498df9bb22a18ba1293f09664cec
https://doi.org/10.1159/000227505

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Autor: F. Cognetti, E.M. Ruggeri, A. Felici, M. Gallucci, G. Muto, C.F. Pollera, B. Massidda, A. Rubagotti, D. Giannarelli, F. Boccardo, R. Cantiani, M. Aglietta, O. Bertetto, G.L. Cetto, P. Orlandini, E. Ferrazzi, M. Nardi, Sollievo della Sofferenza, L. Manzione, V. Adamo, G. Porcile, M. Lentini, E. Breda, T. Gamucci, D. Tummarello, L. Dogliotti, S. Tumolo, M. Motta, V. Lo Russo, G. De Grande, C. Sacco, F. Gaion, A. Lavarello, A. Nuzzo, M. Clerico, C. Aragona, A. Gernone, F. Morelli, V. Olivito, null Cupini, R. Mattioli, A. Marra, M. Antimi, V. Silingardi, R. Labianca, A. Martoni, V. Bortolussi, M. Luoni, A. Rosabian, F. Di Vito, G. Catalano, N. Gebbia

Background The purpose of the study was to evaluate the benefit of adjuvant chemotherapy (AC) versus surgery alone in patients with muscle-invasive bladder cancer (MIBC). Patients and methods One hundred and ninety-four patients with pT2G3, pT3–4,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6929c34f62b572c625dc171db791cf6
http://hdl.handle.net/2318/134005

Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma

Autor: Luigi Bortolotti, P. Nelli, P. Manente, G. Sgarbossa, Marco Colleoni, Lamberto Toniolo, Francesco Calabrò, F. Gaion, G. Vicario, Francesco Sartori

Publikováno v: Scopus-Elsevier

Aims and background Malignant mesothelioma is associated with a median survival of 4 to 12 months. Data from the literature indicate that single modality treatment (surgery or intrapleural and/or systemic chemotherapy) does not significantly affect s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24be5f13c2144b2868021885ff96a215
https://pubmed.ncbi.nlm.nih.gov/8623505